Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach

May 11, 2022 updated by: Ostfold Hospital Trust

Osteosynthesis of Intraarticular Calcaneal Fractures: Arthroscopically Assisted Percutaneous Technique Versus Sinus Tarsi Approach - A Randomized Controlled Multicenter Trial

In this randomized controlled trial, the outcomes of two surgical techniques for intraarticular calcaneal fractures will be evaluated and compared.

Study Overview

Detailed Description

Operative treatment of calcaneal features through an extensile lateral approach (ELA) has been the gold standard over many years despite high rates of infection and soft tissue complications.

Lately, there has been a trend towards less invasive fixation methods. Minimally invasive plate osteosynthesis using the sinus tarsi approach (STA) has gained popularity during the last decade.

Furthermore, percutaneous reduction and fixation techniques have been described and used for a few decades. In the early 2000s, Rammelt et al. were the first who introduced a percutaneous technique assisted by hindfoot arthroscopy. The percutaneous and arthroscopically assisted calcaneal osteosynthesis (PACO) is applicable in Sanders II and III fractures and has been shown to provide good clinical outcomes as well as a low rate of complications.

The study is designed as a superiority study. Our hypothesis is that the percutaneous and arthroscopically assisted technique provides superior outcomes compared to the sinus tarsi approach in Sanders II and III calcaneal fractures.

Study Type

Interventional

Enrollment (Anticipated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bergen, Norway
      • Drammen, Norway
        • Recruiting
        • Vestre Viken Hospital Trust - Drammen hospital
        • Contact:
      • Oslo, Norway, 0588
        • Recruiting
        • Oslo university hospial
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Elisabeth Ellingsen Husebye, MD, PhD
      • Sandvika, Norway
        • Recruiting
        • Vestre Viken Hospital Trust - Bærum hospital
        • Contact:
    • Østfold
      • Sarpsborg, Østfold, Norway, 1714

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 68 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Dislocated intraarticular calcaneal fracture, type Sanders II or Sanders III with an intraarticular step > 2mm
  • Patients between 18 and 70 years of age
  • Acute presentation at one of our departments, enabling surgery within 10 days after injury

Exclusion Criteria:

  • Intraarticular step of < 2mm
  • Sanders IV fractures
  • Open fractures
  • Bilateral injuries
  • Concomitant major injuries of the foot, ankle or leg that affect the rehabilitation process
  • Multitraumized patients
  • Previous injury or surgery of the hindfoot
  • Charcot foot
  • Serious medical condition that contradicts surgery
  • Noncompliant patients
  • Insufficient Norwegian or English language skills
  • Patients not available for follow-up
  • Inability to conduct the rehabilitation protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Sinus tarsi approach (STA)
Patients randomized to this arm are operated with plate osteosynthesis via the sinus tarsi approach
Osteosynthesis
Active Comparator: Percutaneous Arthroscopically Assisted Osteosynthesis (PACO)
Patients randomized to this arm are operated with percutaneous reduction of the fracture and osteosynthesis with screws, assisted by subtalar arthroscopy
Osteosynthesis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Manchester-Oxford Foot Questionnaire (MOxFQ)
Time Frame: 5 years
Foot-Ankle specific PROM (0-100 with 0 representing the best possible outcome)
5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-reported foot and ankle score (SEFAS)
Time Frame: 5 years
Foot-Ankle specific PROM (0-48 with 48 representing the best possible outcome)
5 years
Visual Analogue Scale (VAS) for pain
Time Frame: 5 years
Scores pain at rest and on activity (0-10 with 0 representing no pain)
5 years
American Orthopaedic Foot and Ankle Society (AOFAS) Ankle-Hindfoot score
Time Frame: 5 years
Widely used foot/ankle score (0-100 with 100 representing the best possible outcome)
5 years
Calcaneus Fracture Scoring System (CFSS)
Time Frame: 5 years
Calcaneal fracture specific scoring system (0-100 with 100 representing the best possible outcome)
5 years
Incidence of complications
Time Frame: 5 years
Yes/no for deep or superficial infection, nerve or tendon injury, deep venous thrombosis, hardware complaints and secondary surgery
5 years
Böhler angle
Time Frame: 5 years
Böhler angle pre- and post surgery as well as at follow up
5 years
Subtalar osteoarthritis
Time Frame: 5 years
The presence of subtalar osteoarthritis is graded based CT scans taken at the 2 year and 5 year follow-up using the Kellgren & Lawrence classification system.
5 years
EQ-5D-5L
Time Frame: 5 years
Measure of health-related quality of life. This will be evaluated at the 2-year and 5 -year follow-up.
5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Are Stødle, MD, Oslo University Hospital
  • Principal Investigator: Frede Frihagen, MD, PhD, Ostfold Hospital Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2020

Primary Completion (Anticipated)

December 1, 2030

Study Completion (Anticipated)

December 1, 2031

Study Registration Dates

First Submitted

April 29, 2020

First Submitted That Met QC Criteria

April 29, 2020

First Posted (Actual)

May 4, 2020

Study Record Updates

Last Update Posted (Actual)

May 18, 2022

Last Update Submitted That Met QC Criteria

May 11, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20/00912

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Calcaneus Fracture

Clinical Trials on Sinus tarsi approach (STA)

3
Subscribe